Form 4: Artivion SVP's Routine Stock Activity Post-PSU Vesting

Artivion's SVP, Marshall S. Stanton, reported the vesting of performance stock units and a subsequent 'sell to cover' transaction for tax obligations.

Summary

• Marshall S. Stanton, SVP, Clinical & MD Affair at Artivion, Inc. (AORT), reported changes in beneficial ownership.
• On March 2, 2026, 21,838 shares of Common Stock were acquired at a price of $0, representing the vesting of one-third of performance stock units granted on February 28, 2025.
• Following this acquisition, Stanton's beneficial ownership was 62,246 shares.
• On March 3, 2026, 2,149 shares of Common Stock were disposed of at a price of $37.7756 per share.
• This disposition was a 'sell to cover' transaction to satisfy tax withholding obligations upon the vesting of the performance stock units and was not a discretionary sale.
• After the disposition, Stanton's beneficial ownership stands at 60,097 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The vesting of PSUs is positive as it indicates performance achievement, but the subsequent tax-related sale is a routine, non-discretionary event that does not provide strong directional sentiment.

Positives

• The vesting of 21,838 performance stock units indicates the achievement of performance criteria set by the company for executive compensation.

Negatives

• A total of 2,149 shares were sold, reducing the direct beneficial ownership of the SVP, although this was for tax purposes and not a discretionary sale.

Future Outlook

The remaining performance stock units from the February 2025 grant are scheduled to vest in two equal tranches: one-third on February 28, 2027, and the final one-third on February 28, 2028, contingent upon continued employment.

Management Comments

• The sale of 2,149 shares was executed upon the vesting of performance stock units specifically to pay tax withholding obligations, funded by a 'sell to cover' transaction, and is explicitly stated as not representing a discretionary transaction.

Industry Context

StockSavvy.ai notes that the vesting of performance stock units and subsequent 'sell to cover' transactions for tax purposes are standard components of executive compensation packages across various industries. This type of insider transaction is generally considered routine and does not typically signal a change in management's outlook on the company's prospects.

Stakeholder Impact

• Shareholders: The transaction is a routine insider compensation event and is unlikely to have a significant direct impact on shareholder value or perception. It reflects standard executive compensation practices.

Next Steps

• One-third of the remaining performance stock units are eligible to vest on February 28, 2027.
• The final one-third of the performance stock units are eligible to vest on February 28, 2028.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation, specifically the vesting of performance stock units and a non-discretionary 'sell to cover' sale for tax obligations. Such transactions typically do not provide a strong signal for investment decisions, as they are pre-planned and not indicative of management's discretionary view on the company's immediate prospects. Therefore, a 'hold' recommendation is appropriate as this filing does not present new information warranting a change in investment stance.

Keywords

Artivion, AORT, Form 4, Insider Transaction, Performance Stock Units, PSU Vesting, Executive Compensation, Sell to Cover, Beneficial Ownership